NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-101261

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedOveractive bladder
Date of first enrollment01/9/2010
Target sample size320
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : SMP-986 Dosage And administration of the intervention : Oral Control intervention name : placebo Dosage And administration of the control intervention : Oral

Outcome(s)

Primary OutcomeEfficacy: Change from baseline in number of voids per day At 12 weeks
Secondary OutcomeEfficacy: Change from baseline in number of urgency episodes per day At 12 weeks

Key inclusion & exclusion criteria

Age minimum20
Age maximum80
GenderBOTH
Include criteriaPatient with overactive bladder who meets the following criteria - Outpatient - Patient has overactive bladder syndrome over a successive period of at least 6 months prior to onset of the study - Patient can get to a bathroom without assistance and can record the bladder diary accurately
Exclude criteria- Patient with bladder outlet obstruction - Patient has a neurological disease which has potential to cause overactive bladder syndrome - Patient has a polyuria

Related Information

Contact

public contact
Name Dainippon Sumitomo Pharma Co., Ltd Corporate Communications
Address http://www.ds-pharma.com/inquiry/index.html
Telephone
E-mail
Affiliation
scientific contact
Name Dainippon Sumitomo Pharma Co., Ltd Corporate Communications
Address http://www.ds-pharma.com/inquiry/index.html
Telephone
E-mail
Affiliation